Professor Colin Lindsay
Professor Colin Lindsay
Professor of Molecular Oncology
Colin Lindsay is Professor of Molecular Oncology at the University of Manchester and an Honorary Consultant Medical Oncologist at The Christie NHS Foundation Trust. His research career began at the CRUK Beatson Institute in Glasgow, where his PhD explored RAS/RAF-driven cancers, followed by translational training in lung cancer at Gustave Roussy Institute in France. He has since developed an internationally focused research programme in RAS precision medicine.
His current research focuses on understanding the biology of RAS-driven lung cancers and translating those discoveries into better treatments for patients. His programme integrates patient samples, laboratory models and biomarker development with clinical research, including RAS-BIO, a dedicated translational biobank for patients with RAS-driven tumours. This provides a platform for studying different RAS mutations, treatment response and resistance, and identifying new therapeutic approaches.
Alongside his laboratory and translational research, Colin Lindsay leads and contributes to major national and international clinical trials of new targeted treatments for RAS-mutant lung cancer. His work spans the pathway from laboratory discovery through to late-phase trials, with the overall aim of developing more effective, personalised treatment strategies for patients with RAS-driven cancers.